Tomer Kariv's Insider Trades & SAST Disclosures
Tomer Kariv's most recent trade in Keros Therapeutics Inc was a trade of 10,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 30, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Tomer Kariv.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Eloxx Pharmaceuticals Inc | Tomer Kariv | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 2,859 | 2,859 | - | - | Stock Options (Right to Buy) | |
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | 29 Nov 2022 | 3,539 | 2,284,612 | - | 0 | Common Stock | ||
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | 29 Nov 2022 | 3,539 | 0 | - | - | Call Options (obligation to sell) | ||
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | 29 Nov 2022 | 1,914 | 0 | - | - | Call Options (obligation to sell) | ||
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | 29 Nov 2022 | 1,914 | 1,226,412 | - | 0 | Common Stock | ||
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | 29 Nov 2022 | 1,723 | 0 | - | - | Call Options (obligation to sell) | ||
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | 29 Nov 2022 | 1,723 | 1,121,045 | - | 0 | Common Stock | ||
| Eloxx Pharmaceuticals Inc | Tomer Kariv | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 20,000 | 20,000 | - | - | Stock Options (Right to Buy) | |
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 8,293 | 8,293 | - | - | Stock Options (right to buy) | |
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 8,293 | 8,293 | - | - | Stock Option (right to buy) | |
| Eloxx Pharmaceuticals Inc | Tomer Kariv | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Eloxx Pharmaceuticals Inc | Tomer Kariv | Director | Purchase of securities on an exchange or from another person at price $ 1.35 per share. | 13 May 2021 | 2,630,487 | 3,679,797 (9%) | 6% | 1.3 | 3,551,157 | Common Stock |
| Eloxx Pharmaceuticals Inc | Tomer Kariv | Director | Purchase of securities on an exchange or from another person at price $ 1.35 per share. | 13 May 2021 | 1,422,222 | 1,989,551 (4%) | 3% | 1.4 | 1,920,000 | Common Stock |
| Eloxx Pharmaceuticals Inc | Tomer Kariv | Director | Purchase of securities on an exchange or from another person at price $ 1.35 per share. | 13 May 2021 | 1,280,624 | 1,791,470 (4%) | 3% | 1.3 | 1,728,842 | Common Stock |
| Eloxx Pharmaceuticals Inc | Tomer Kariv | Director | Purchase of securities on an exchange or from another person at price $ 1.35 per share. | 13 May 2021 | 592,592 | 616,592 (1%) | 1% | 1.3 | 799,999 | Common Stock |
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 50.00 per share. | 17 Nov 2020 | 26,634 | 2,288,151 | - | 50 | 1,331,700 | Common Stock |
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 50.00 per share. | 17 Nov 2020 | 14,400 | 1,228,326 | - | 50 | 720,000 | Common Stock |
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 50.00 per share. | 17 Nov 2020 | 12,966 | 1,122,768 | - | 50 | 648,300 | Common Stock |
| Keros Therapeutics Inc | Tomer Kariv | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 50.00 per share. | 17 Nov 2020 | 6,000 | 155,262 | - | 50 | 300,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges